A Berry-Sized Thermometer Measures Body Temp. But You Have to Eat It.

Why It Matters

Continuous, high‑resolution core temperature data can enable earlier infection detection and improve patient safety, especially for immunocompromised or peri‑operative individuals, while removing the discomfort of rectal probes.

Key Takeaways

• MIT's ingestible thermometer measures temperature to 0.01 °C accuracy.
• Capsule size: 4 mm high, 6 mm diameter, smaller than existing pills.
• Powered by 10 nW, uses backscatter communication for near‑zero energy use.
• Tested in pigs, continuously relayed data once per second.
• Potential uses: anesthesia monitoring, fertility tracking, athletes, immunocompromised patients.

Pulse Analysis

Accurate temperature measurement is a cornerstone of clinical assessment, yet conventional oral or forehead thermometers provide only surface readings that can miss early signs of infection or hypothermia. In surgical settings, anesthesia disrupts the body’s thermoregulatory mechanisms, creating a narrow window where rapid core temperature changes can jeopardize outcomes. Existing ingestible sensors are often the size of multivitamins, posing swallowing challenges and a risk of gastrointestinal blockage, limiting their widespread adoption for continuous monitoring.

The MIT team tackled these hurdles by engineering a capsule the size of a small berry. By integrating a 1‑mm² silicon temperature‑sensing chip, a 1.55‑volt coin cell, and a miniature backscatter antenna, they achieved a power draw of just 10 nanowatts—orders of magnitude lower than traditional designs. The sensor’s leakage‑current‑based oscillator translates minute temperature shifts into frequency changes, enabling 0.01 °C resolution. Backscatter communication offloads most of the energy demand to an external antenna, allowing the capsule to broadcast temperature data once per second without depleting its tiny battery.

Beyond the lab, the technology promises to reshape remote health monitoring and hospital care. Continuous core temperature data could alert clinicians to febrile spikes in immunosuppressed patients, guide peri‑operative warming protocols, and even support fertility tracking by detecting ovulation‑related thermal patterns. As the device moves toward human trials, integration with additional vitals—such as heart rate or oxygen saturation—could create a comprehensive ingestible health platform, opening new revenue streams for med‑tech firms and offering a non‑invasive alternative to traditional thermometry.